Nuclein, LLC

Nuclein, LLC is an in vitro diagnostics company specializing in rapid, point-of-care molecular diagnostic solutions for infectious diseases. Based in Austin, Texas and founded in 2017, the company develops portable, battery-powered PCR platforms that deliver lab-quality results in approximately 15 minutes without requiring traditional laboratory infrastructure. The flagship DASH Rapid PCR System is an FDA-cleared, CLIA-waived platform featuring an intuitive user interface, room-temperature cartridge storage, Wi-Fi and cloud connectivity, and multiplex-capable testing in a single cartridge. The system supports multiple sample types and has a compact footprint (15"D x 11"H x 4"W). Nuclein's current test menu includes the DASH SARS-CoV-2 & Flu A/B Test with dual FDA clearance, with plans to expand to additional infectious disease and condition testing. The platform is designed for healthcare settings, urgent care, clinics, and other point-of-care environments where rapid, accurate molecular diagnostics can inform immediate treatment decisions.